The first in a series of Dotmatics Luma Multimodal R&D Solutions Geneious has been seamlessly composed into Luma showcasing cross-therapeutic…
Study to evaluate PDS01ADC + Xtandi® (Enzalutamide) versus Xtandi® alone to be presented by Dr. Ravi Madan, National Cancer Institute…
Company to conduct a Phase 1 Drug-Drug Interaction StudyPhase 2 filing on track for Q1 2025 SOUTH SAN FRANCISCO, Calif.,…
Determined the high dose of OCU410ST to be the maximum tolerated doseNo serious adverse events have been reportedApproved proceeding to…
Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expandsto include treatment of adults…
Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expandsto include treatment of adults…
Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expandsto include treatment of adults…
The Bioprocessing Market share is expected to reach US$ 72.55 billion by 2031 from US$ 25.35 billion in 2023 to record…
RIYADH, Saudi Arabia, Oct. 21, 2024 /PRNewswire/ -- The seventh edition of the Global Health Exhibition has kicked off under the…
Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+…